Rami S Komrokji

99PUBLICATIONS
464CO-AUTHORS
Medical mycologyGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)HaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (99)

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

|Jun 05, 2026
Hematologic Responses Achieved with Luspatercept in Higher-Risk Myelodysplastic Syndromes.

|May 06, 2026
Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

Pageof 17

Frequent Collaborators

43 joint publications

David Sallman

20 joint publications

Onyee Chan

19 joint publications

Eric Padron

19 joint publications

Valeria Santini